F-star Therapeutics Profit Margin

As of the most recent data (September 2022), FSTX shows a profit margin of -212.48%. That compares with -1170.87% in the prior-year period — up 81.9% year over year. That is below the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FSTX's profit margin is now -212.48% (was -1170.87%) — a 81.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether F-star Therapeutics is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. F-star Therapeutics is at -212.48%, which is lower that average. That is roughly 1095.9% below the sector mean. Use the comparison chart on this page to see how FSTX stacks up against individual peers as well.

That compares with -1170.87% in the prior-year period — up 81.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare F-star Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has F-star Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -212.48%) with ownership activity and broader fundamentals.